SJS Investment Consulting’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.8K Buy
812
+809
+26,967% +$7.23K ﹤0.01% 1556
2026
Q2
$30 Buy
+3
New +$30 ﹤0.01% 2804
2023
Q1
– Sell
-43
Closed -$2.59K – 1618
2022
Q4
$2.59K Buy
43
+38
+760% +$2.22K ﹤0.01% 526
2022
Q3
$0 Buy
+5
New +$158 ﹤0.01% 1443

Other funds holding PRTA

SJS Investment Consulting's PRTA Position: Q3 2026 in Review

SJS Investment Consulting increased its Prothena Corp (PRTA) stake by 26,967% in Q3 2026, buying an estimated $7.23K and bringing the position to 812 shares worth $6.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

SJS Investment Consulting first reported a position in PRTA in Q3 2022 and has held it in 4 quarters since. 106 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • SJS Investment Consulting held 812 shares of Prothena Corp worth $6.8K as of Q3 2026.
  • SJS Investment Consulting bought 809 Prothena Corp shares in Q3 2026, an estimated $7.23K.
  • Prothena Corp made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1556 holding.
  • SJS Investment Consulting first reported a position in Prothena Corp in Q3 2022 and has held it in 4 quarters since.
  • 106 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.